ArticleCancers2026

Loss of SALL1 Promotes Hepatocellular Carcinoma Growth and Is Associated with Poor Clinical Outcome.

Yoshifumi Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.